With an EV of ~$26m and a quarterly revenue expected in the range of $14-15m, with net profit margin of 30%+++, this is surely the most undervalued company on the ASX. Hopefully the market wakes up to this fact early next week. It’s not inconceivable that by financial year end the company has more cash on its balance sheet than the market cap of the whole company.
- Forums
- ASX - By Stock
- ATP - General Discussion
ATP
atlas pearls ltd
Add to My Watchlist
0.00%
!
16.0¢

With an EV of ~$26m and a quarterly revenue expected in the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.24M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 16.0¢ | $6.563K | 41.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1000621 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 279351 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1000621 | 0.155 |
6 | 107415 | 0.150 |
4 | 280317 | 0.145 |
15 | 868439 | 0.140 |
8 | 207901 | 0.135 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 279351 | 4 |
0.165 | 567997 | 10 |
0.170 | 217971 | 6 |
0.175 | 200196 | 4 |
0.180 | 125000 | 2 |
Last trade - 11.12am 27/06/2025 (20 minute delay) ? |
Featured News
ATP (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online